section name header

Pronunciation

al-FAL-fuh

Classifications

Therapeutic Classification: lipid-lowering agents

Indications

Complementary/Alternative Medicine: This monograph describes a natural or herbal product that is not subject to FDA guidelines for medicines. Patients and clinicians are advised to read package labels carefully to ensure safe and efficacious use.

REMS


Action

  • Alfalfa leaf contains saponins which bind serum cholesterol and decrease its absorption. Alfalfa also contains manganese which may be responsible for hypoglycemic effects and isoflavonoids which have estrogenic properties.
Therapeutic effects:
  • Decreased cholesterol levels.
  • Decreased blood glucose levels.

Pharmacokinetics

Absorption: Unknown.

Distribution: Unknown.

Metabolism/Excretion: Unknown.

Half-Life: Unknown.

Time/Action Profile

ROUTEONSETPEAKDURATION
POUnknownUnknownUnknown

Contraind./Precautions

Contraindicated in:

Use Cautiously in:

Adv. Reactions/Side Effects

Derm: dermatitis

Endo: hypoglycemia

F and E: hypokalemia

GI: GI upset, diarrhea, flatulence

Hemat: pancytopenia

Misc: lupus-like syndrome, photosensitivity

Interactions

Natural-Drug Products:

Natural-Natural Products:

Route/Dosage

Availability

Assessment

Lab Test Considerations:

Implementation

Patient/Family Teaching

Evaluation/Desired Outcomes

US Brand Names

Medicago sativa